Tokyo, Japan

Atsushi Miyajima

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 3.7

ph-index = 1

Forward Citations = 29(Granted Patents)


Company Filing History:


Years Active: 2003-2024

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Atsushi Miyajima: Innovator in Hepatic Cell Research

Introduction

Atsushi Miyajima is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of hepatic cell research, holding a total of 4 patents. His work focuses on the preparation and application of various liver cells, which have important implications for medical research and treatment.

Latest Patents

Miyajima's latest patents include innovative methods for preparing hepatocytes and hepatic non-parenchymal cells. One notable invention pertains to a comprehensive approach to hepatocytes, liver progenitor cells, cholangiocytes, and other liver-related cell types. This invention also includes methods for preparing these cells and a pharmaceutical composition or kit that incorporates them. Additionally, he has developed methods for screening liver disease treatment agents and evaluating the hepatotoxicity of drugs. Another significant patent involves a method for preparing a cell fraction containing hemangioblasts, which are crucial for understanding hematopoietic stem cell activity.

Career Highlights

Throughout his career, Atsushi Miyajima has worked with reputable organizations, including Schering Corporation and The University of Tokyo. His research has been instrumental in advancing the understanding of liver diseases and potential treatments.

Collaborations

Miyajima has collaborated with notable colleagues such as Takahiko Hara and Daniel J Dairaghi. These partnerships have further enriched his research and contributed to the development of innovative solutions in the field.

Conclusion

Atsushi Miyajima's contributions to hepatic cell research and his innovative patents highlight his role as a leading inventor in this vital area of medical science. His work continues to pave the way for advancements in liver disease treatment and cellular therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…